Scientists test new cystic fibrosis drug form in healthy volunteers
NCT ID NCT06299709
Summary
This early-stage study tested a new granule form of a cystic fibrosis drug combination in healthy adults. Researchers wanted to see how the body absorbs the granules, if taking them with food makes a difference, and if different doses work as expected. The main goal was to gather safety and absorption data to help design future studies for people with cystic fibrosis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion, Inc.
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.